HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 182 filers reported holding HAEMONETICS CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $51,000 | -16.4% | 1,300 | -13.3% | 0.05% | -4.0% |
Q1 2017 | $61,000 | -68.4% | 1,500 | -68.8% | 0.05% | -36.7% |
Q4 2016 | $193,000 | +56.9% | 4,800 | +41.2% | 0.08% | -3.7% |
Q3 2016 | $123,000 | +192.9% | 3,400 | +183.3% | 0.08% | +182.8% |
Q1 2016 | $42,000 | – | 1,200 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
Dean Capital Management | 15,309 | $812,000 | 0.70% |
Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |